Literature DB >> 27726178

Critical role of Ror2 receptor tyrosine kinase in regulating cell cycle progression of reactive astrocytes following brain injury.

Mitsuharu Endo1, Guljahan Ubulkasim1, Chiho Kobayashi1, Reiko Onishi1, Atsu Aiba2, Yasuhiro Minami1.   

Abstract

Ror2 receptor tyrosine kinase plays crucial roles in developmental morphogenesis and tissue-/organo-genesis. In the developing brain, Ror2 is expressed in neural stem/progenitor cells (NPCs) and involved in the regulation of their stemness. However, it remains largely unknown about its role in the adult brain. In this study, we show that Ror2 is up-regulated in reactive astrocytes in the neocortices within 3 days following stab-wound injury. Intriguingly, Ror2-expressing astrocytes were detected primarily at the area surrounding the injury site, where astrocytes express Nestin, a marker of NPCs, and proliferate in response to injury. Furthermore, we show by using astrocyte-specific Ror2 knockout (KO) mice that a loss of Ror2 in astrocytes attenuates injury-induced proliferation of reactive astrocytes. It was also found that basic fibroblast growth factor (bFGF) is strongly up-regulated at 1 day post injury in the neocortices, and that stimulation of cultured quiescent astrocytes with bFGF restarts their cell cycle and induces expression of Ror2 during the G1 phase predominantly in proliferating cells. By using this culture method, we further show that the proportions of Ror2-expressing astrocytes increase following treatment with the histone deacetylases inhibitors including valproic acid, and that bFGF stimulation increases the levels of Ror2 expression within the respective cells. Moreover, we show that bFGF-induced cell cycle progression into S phase is inhibited or promoted in astrocytes from Ror2 KO mice or NPCs stably expressing Ror2-GFP, respectively. Collectively, these findings indicate that Ror2 plays a critical role in regulating the cell cycle progression of reactive astrocytes following brain injury, GLIA 2016. GLIA 2017;65:182-197.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  basic fibroblast growth factor (bFGF); gene expression; proliferation

Mesh:

Substances:

Year:  2016        PMID: 27726178     DOI: 10.1002/glia.23086

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  6 in total

1.  The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle.

Authors:  Koki Kamizaki; Ryosuke Doi; Makoto Hayashi; Takeshi Saji; Motoi Kanagawa; Tatsushi Toda; So-Ichiro Fukada; Hsin-Yi Henry Ho; Michael Eldon Greenberg; Mitsuharu Endo; Yasuhiro Minami
Journal:  J Biol Chem       Date:  2017-08-08       Impact factor: 5.157

2.  Agrin-Lrp4-Ror2 signaling regulates adult hippocampal neurogenesis in mice.

Authors:  Hongsheng Zhang; Anupama Sathyamurthy; Fang Liu; Lei Li; Lei Zhang; Zhaoqi Dong; Wanpeng Cui; Xiangdong Sun; Kai Zhao; Hongsheng Wang; Hsin-Yi Henry Ho; Wen-Cheng Xiong; Lin Mei
Journal:  Elife       Date:  2019-07-03       Impact factor: 8.140

Review 3.  The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention.

Authors:  Kerstin Menck; Saskia Heinrichs; Cornelia Baden; Annalen Bleckmann
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

Review 4.  The Ror-Family Receptors in Development, Tissue Regeneration and Age-Related Disease.

Authors:  Mitsuharu Endo; Koki Kamizaki; Yasuhiro Minami
Journal:  Front Cell Dev Biol       Date:  2022-04-13

Review 5.  Axon Guidance Molecules and Pain.

Authors:  Elisa Damo; Manuela Simonetti
Journal:  Cells       Date:  2022-10-06       Impact factor: 7.666

6.  Embedding of lamellar hole-associated epiretinal proliferation combined with internal limiting membrane inversion for the treatment of lamellar macular hole: a case report.

Authors:  Yusuke Shiode; Yuki Morizane; Kosuke Takahashi; Shuhei Kimura; Mio Hosokawa; Masayuki Hirano; Shinichiro Doi; Shinji Toshima; Mika Hosogi; Atsushi Fujiwara; Fumio Shiraga
Journal:  BMC Ophthalmol       Date:  2018-09-24       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.